Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Joyce de Langen

Joyce de Langen

Senior Solution Manager Pharmacovigilance

Connect with Joyce de Langen on LinkedIn
Follow Joyce de Langen on Twitter
Website:

About the author:

I am a pharmacist by training. I joined Elsevier last month as Senior Solution Manager Pharmacovigilance. I am working in the pharmacovigilance and drug safety domain for more than 10 years. I started my professional career at the Netherlands Pharmacovigilance Centre for spontaneous adverse event reporting. After 6 years I teached pharmacotherapy and pharmacoepidemiology at the University of Utrecht and the last 5 years of my professional live I worked in the pharmaceutical industry (Abbott/AbbVie and Sanquin Plasma Products) in different roles within pharmacovigilance. Prior to working to Elsevier I was the qualified person for pharmacovigilance with Sanquin Plasma Products.


Posts by Joyce de Langen

Text Mining for Pharmacovigilance Purposes

Posted on July 7th, 2016 in Pharmacovigilance

Text mining, or text data mining, is the process of retrieving relevant information from large amounts of ‚Äėunstructured‚Äô text with the help of automated pattern learning. Continue reading “Text Mining for Pharmacovigilance Purposes” »

The Role of Scientific Literature in Pharmacovigilance: Challenges and Solutions

Posted on May 6th, 2016 in Pharmacovigilance

Medical-Literature

After our recent webinar, Elsevier received several¬†questions¬†from attendees. During the next few weeks, we will discuss some of the¬†questions¬†in more detail.¬† Continue reading “The Role of Scientific Literature in Pharmacovigilance: Challenges and Solutions” »

EMA Yearly Update on MLM – highlights and next steps

Posted on January 19th, 2016 in Pharmacovigilance

EMA¬† Pharmacovigilance Programme Update Issue 6 ‚Äď Preparing for Business Change

Since July 2014, EMA provides quarterly Pharmacovigilance Programme Updates to Marketing Authorisation Holders (MAHs). Continue reading “EMA Yearly Update on MLM – highlights and next steps” »

  1. 1
  2. 2